Bowen Matthew
SEC CIK 2115025 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | Principal Accounting Off | 25.9K | — | — | 1 | 2026-04-06 | 2026-04-06 |
Most active insiders at GLUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Janku Filip | Chief Medical Off | — | $1.38M |
| 2 | Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| 3 | Dunn Edmund | Principal Accounting Off | — | $483.1K |
| 4 | Townson Sharon | CSO | — | $423.9K |
| 5 | Manning Anthony M. | Dir | — | $411.2K |
| 6 | Champoux Jennifer | COO | — | $311.3K |
| 7 | Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| 8 | Bowen Matthew | Principal Accounting Off | — | — |
| 9 | Behbahani Ali | Dir | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-07 16:10 | 2026-04-06 | GLUE | Monte Rosa Therapeutics, Inc. | Bowen Matthew | Principal Accounting Off | A - Grant | — | +4,300 | 25.9K | +20% | — |
Purchase Sale Sale after option exercise All abbreviations